Speech Therapy Pediatric denied for failing step therapy by Cigna?

Cigna's specific coverage criteria for speech therapy pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Pediatric Speech Therapy via "Step Therapy" — and Why That Is Often Inapplicable

Step therapy — sometimes called "fail-first" — is a protocol typically applied to medications, requiring a patient to try and fail a lower-cost drug before a preferred one is covered. When Cigna applies a step-therapy denial to pediatric speech therapy, it usually means the plan is requiring documentation that less intensive interventions (such as school-based services, home-practice programs, or a lower frequency of therapy) were attempted first. This is appealable, particularly when the treating clinician has determined that the prescribed intensity is the medically appropriate starting point for the child's specific diagnosis and severity.

## Why This Denial Is Appealable

Numerous states have enacted step-therapy override laws that require insurers to grant an exception when a required prior step is contraindicated, has been tried and failed, or when requiring it would cause clinically significant harm. Even in states without specific statutes, the ACA (§2719) and ERISA (§503) provide the right to a full internal appeal and independent external review, generally with an external review window of approximately four months from the denial notice. Expedited review is available when delay would jeopardize the child's health or developmental trajectory.

## Concrete Appeal Process

1. Identify the specific step required — obtain Cigna's written denial with the exact step-therapy criterion, including what prior treatment Cigna claims was required. 2. Assess whether an exception applies — the treating SLP and physician should evaluate whether the required "step" is clinically inappropriate for this child's condition. 3. File a Level 1 internal appeal with a step-therapy exception request, within the EOB deadline. 4. Request external review if the Level 1 is upheld. 5. Review state-specific step-therapy override laws — your state may have explicit procedures and timelines for step-therapy exceptions that are more protective than federal minimums.

## Documentation to Gather

• Diagnosis and clinical severity: A comprehensive SLP evaluation showing the type, severity, and functional impact of the communication disorder, supporting why a specific intensity of treatment is medically necessary at the outset.
• Prior treatment history: Dates, providers, frequencies, and outcomes of any previous speech therapy or related interventions, including school-based services, demonstrating what has already been tried.
• Step-therapy exception basis: A signed letter from the treating SLP and referring physician explaining specifically why the required prior step is clinically inappropriate, has already been completed, or would cause harm if imposed now.
• Developmental impact statement: Documentation of how delayed or reduced treatment would affect the child's communication development, educational access, and social functioning.
• Relevant guideline reference: The treating provider should cite applicable clinical guidelines from ASHA or relevant professional bodies without asserting specific numeric benchmarks.

## Criteria-Mapping Structure

Request Cigna's step-therapy coverage policy in writing. List every required prior step or exception criterion. For each, document the specific clinical fact from the child's record that either satisfies or provides grounds for waiving that step. Frame the appeal as a structured response to each criterion — this format is the most effective approach before both internal reviewers and independent external reviewers.